Boris Nikolic is Director at Editas Medicine, Inc. (EDIT). They have made 1 open-market trade across 1 company since 2017, most recently 2017-06-02.
CIK 0001657378
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $492K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EDIT | 35,000 | $83K |
Shares reported on the most recent Form 4, priced at the 2017-06-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EDIT | BUY | 2017-06-02 | 2017-06-06 | $14.07 | $492K | +11.8% | +16.9% | +37.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.